Clinical Trials Logo

Subacute Thyroiditis clinical trials

View clinical trials related to Subacute Thyroiditis.

Filter by:
  • None
  • Page 1

NCT ID: NCT06285617 Not yet recruiting - Clinical trials for Subacute Thyroiditis

Short-Term Versus 6-Week Prednisone in The Treatment of Subacute Thyroiditis

SAT
Start date: April 1, 2024
Phase: Phase 3
Study type: Interventional

The goal of this clinical trial is to compare the efficacy and safety of short-term versus 6-week prednisone in the treatment of moderate-to-severe subacute thyroiditis. The main questions it aims to answer are: Does the short-term medication regimen reduce glucocorticoid side effects while achieving similar efficacy as the guideline treatment group? Patients with moderate-to-severe symptoms were randomly assigned to receive either 30 mg/day prednisone for 1 week, followed by 1 week of nonsteroidal anti-inflammatory drugs, or the conventional 6-week prednisone therapy in the control group.

NCT ID: NCT05070091 Completed - COVID-19 Clinical Trials

The Impact of Pituitary-thyroid and Pituitary-adrenal Axes Function on COVID-19 Clinical Course.

ENDO-COVID19
Start date: January 26, 2021
Phase:
Study type: Observational

The main focus of the study is the assessment of hormonal function in the course of COVID-19 infection with special regard for trends predicting clinical events defined as primary endpoints of the study.

NCT ID: NCT01837433 Completed - Clinical trials for Subacute Thyroiditis

Short-term Prednisone to Treat STA Study(SPTSS)

STA
Start date: March 2013
Phase: Phase 4
Study type: Interventional

Efficiency and Safety Study of Short-term Prednisone to Treat Moderate and Severe Subacute Thyroiditis The investigators hypothesize that less adverse reactions will be observed, comparing with the guidelines recommend. The recurrence rate, adrenal insufficiency, temporary and permanent hypothyroidism aren't significant difference.